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aneurysm wall, reducing the overlap while leaving the
bifurcation and limbs stable within the distal aneurysm,
and ameliorating the proximal displacement forces.
We have experimented with alternate designs, including
locking the bifurcate portion to the tubular portion of the
device, or improving the crush resistance of stents
deployed within fenestrations. However, the same funda-
mental principles apply to any design regardless of any
subtle differences. They include the following:
(1) Ensure optimal proximal fixation (active fixation in
healthy aorta).
(2) Ensure optimal distal fixation (rest bifurcate portion on
the bifurcation and secure the limbs within healthy
segments of the iliac arteries).
(3) Ensure maximal overlap between the bifurcate and
tubular components.
(4) Allow the two components to reach a minimal stressed
state, mitigating the downward forces on the proximal
portion of the device.
These principles are adhered to in our practice, and
perhaps explain the absence of this complication in all
implants after 2004.
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Comment on ‘‘Long-Term Results using
Catheter-directed Thrombolysis in 103 Lower Limbs
with Acute Iliofemoral Venous Thrombosis’’
Dear Editor,
I have read with interest the article published by Baekgard
et al. regarding a single center’s experience with catheter
directed thrombolysis of iliofemoral venous thrombosis.1
This article demonstrates potential benefits of thrombolysis
in the treatment of deep vein thrombosis, especially in the
prevention of late complications. However, some additional
data would have been helpful. Anticoagulant treatment
may affect recurrence rate and therefore, indirectly, local
complication rate. Treatment duration is a matter of
debate but probably should be tailored according to patient
characteristics.2,3 It would therefore have aided to our
understanding if Baekgaard and colleagues added the
information regarding their patient’s anticoagulation regi-
mens and adherence. Furthermore, graded compression
stockings may have yet another beneficial effect in pre-
venting the post-phlebitic syndrome.4 Report of the use of
such devices in the studied population could have added
more to our understanding of the actual benefits of cath-
eter directed thrombolysis in preventing late complications
of deep vein thrombosis.
Thank you.
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Response to comment on ‘‘Long-Term Results using
Cateter-directed Thrombolysis in 103 Lower Limbs
with Acute lliofemoral Venous Thrombosis’’
Dear Dr Weinberg,
Thank you very much for your comments to our publication.
We agree that several additional procedures could be
important for our excellent results in this series, and among
these the beneficial of using compression stockings and
securing sufficient anticoagulation treatment. However, we
doubt that these additional treatment modalities are the
main course for the success of catheter-directed throm-
bolysis for deep venous thrombosis in our material. The fact
that the immediate thrombus removal is almost 100 % is in
our mind unrelated to the factors mentioned above. In the
abstract we have prescribed compression stockings and
anticoagulation using warfarin for at least 1 year, and
indefinitely in patients with severe thrombophilia.
Approximately one third of the patients are receiving long-
life anticoagulation. The long term results most logically
must be due to the early thrombus removal thereby saving
patency and valve function in these patients with iliofe-
moral deep venous thrombosis. In our experience we
seldom observe spontaneous thrombolysis in patients with
iliofemoral deep venous thrombosis.
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